Huntington's disease progression-Reference-Cited by-同舟云学术

Huntington's disease progression

Published:1999-12 Issue:12 Volume:122 Page:2353-2363
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Andrews Thomasin C.,Weeks Robert A.,Turjanski Nora,Gunn Roger N.,Watkins Laura H. A.,Sahakian Barbara,Hodges John R.,Rosser Anne E.,Wood Nicholas W.,Brooks David J.

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/122/12/2353/17874732/1222353.pdf

Reference44 articles.

1. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci1989; 12: 366–75.

2. Antonini A, Leenders KL. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride. Ann N Y Acad Sci1993; 695: 81–5.

3. Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell Weber M, et al. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain1996; 119: 2085–95.

4. Antonini A, Leenders KL, Eidelberg D. [11C]Raclopride-PET studies of the Huntington's disease rate of progression: relevance of the trinucleotide repeat length. Ann Neurol1998; 43: 253–5.

5. Augood SJ, Faull RL, Emson PC. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann Neurol1997; 42: 215–21.

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of dopaminergic pathways in Huntington’s Disease: when, how, why? A (clinician-friendly) systematic review of the literature on PET and SPECT applications;Clinical and Translational Imaging;2024-07-19

2. PET imaging of dopaminergic system and clinical applications;Clinical and Translational Imaging;2024-05-13

3. Neuroimaging biomarkers in Huntington's disease: Preparing for a new era of therapeutic development;Parkinsonism & Related Disorders;2023-09

4. Multimodality imaging of neurodegenerative disorders with a focus on multiparametric magnetic resonance and molecular imaging;Insights into Imaging;2023-01-16

5. Positron Emission Tomography (PET) Imaging Biomarkers in Huntington’s Disease;Contemporary Clinical Neuroscience;2023